Novo Nordisk's 2024 earnings exceeded estimates, with strong performance in diabetes, obesity, and rare disease segments.

Novo Nordisk shares dropped due to CagriSema trial results but have long-term upside. Learn why NVO stock is a Strong Buy ...

A posh compound in the exclusive neighborhood of Port Royal in Naples, Florida previously made national headlines as the most expensive home for sale in America. Now it has a new price tag.

A small study confirms observations what users have observed: the medications reduce their cravings for alcohol.

Semaglutide really does seem to help people who are addicted ... Sold under brand names including Wegovy and Ozempic, semaglutide works by mimicking a gut hormone called glucagon-like peptide ...

The drug semaglutide has been linked to a lower risk of alcoholism before, but now we have strong evidence that it really ...

Weight-loss and diabetes drug Wegovy (semaglutide) may also help heavy drinkers cut down on their alcohol intake, a randomised controlled trial has found. A US study in 48 people with alcohol use ...

reads text in the print ad, above a needle and vial labeled compounded semaglutide. “Bottom line: If the label doesn’t say Wegovy® (semaglutide) or Ozempic® (semaglutide), it’s not FDA ...

View this interactive chart on Fortune.com Novo Nordisk isn’t impressed. “As makers of the only real FDA-approved semaglutide medicines (Wegovy, Ozempic, and Rybelsus), patient safety remains our top ...

Semaglutide belongs to a class of drugs called incretin mimetics, which imitate gut hormones aiding in blood sugar regulation. In addition to Wegovy, incretin mimetics FDA-approved for chronic ...